Overseas markets lead growth at Japan's Taisho

21 May 2018 - Deborah Wilkes

Archived

Japan's Taisho Pharmaceutical reported Self-Medication sales up by 2.2% to JPY184 billion (USD1.68 billion) in the financial year ended 31 March 2018. Overseas sales were up by 12.4%, but sales in the company's home market only increased by 0.3%.

Click tags below for more information on topics:

Taisho

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: